Abstract
Since the first successful attempts in 1990, human embryonic tissue transplanation has attracted the attention of multiple investigators and clinicians as a serious candidate therapy for Parkinson's disease. Although over two hundred patients have undergone the procedure, multiple issues and questions remain unresolved. We will address this topic emphasizing the recent advances in the technical aspects of the transplantation procedure in light of the limited animal and clinical experience available.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 341-349 |
| Number of pages | 9 |
| Journal | Current Opinion in Neurology |
| Volume | 11 |
| Issue number | 4 |
| DOIs | |
| State | Published - 1998 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Neurology
- Clinical Neurology
Fingerprint
Dive into the research topics of 'Fetal tissue transplanation in Parkinson's disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver